Tag: Heart / Stroke-Related: High Cholesterol
Metabolic Changes With Metformin May Lower LDL-C
Possible metabolic mechanism includes activation of AMPK, FADS suppression
Calculated LDL-C Varies at Lower Values of Measured LDL-C
For calculated LDL-C of 30 mg/dL, 95 percent confidence interval was 24 to 60 mg/dL
FDA Approves Praluent for Certain Cases of High Cholesterol
First in a new class of injectable cholesterol-lowering medications
New Guidelines Deemed Better for Identifying Statin Candidates
New guidelines would have 13 million more Americans taking the cholesterol drugs, experts say
VA/DoD Release Guidelines for Dyslipidemia Management
Key features include elimination of treatment targets, additional testing only when rationale clear
FDA Panel Recommends Approval of Second PCSK9 Inhibitor
Evolocumab (Repatha) for use in patients at very high risk for high cholesterol
FDA Panel Recommends Approval for PCSK9 Inhibitor
Could be used by patients who don't respond to statins
Statins, Fibrates Linked to 30% Lower Stroke Risk in Elderly
But no association between statins and lower risk of coronary heart disease in this group
CDC: Triglyceride Levels Falling for Americans
But many people still at risk
Statins Don’t Reduce Psoriasis Risk
Findings among patients with high, long-term adherence to statins
